Sandbox Reserved 1712
From Proteopedia
(Difference between revisions)
Line 5: | Line 5: | ||
== Function == | == Function == | ||
+ | [[Image:Prote_ALK_Monomer_White.png|400 px|right|thumb|Figure 1]] | ||
+ | [[Image:Proteo_ALK-ALKAL_Monomer_White.png|400 px|right|thumb|Figure 2]] | ||
+ | <scene name='90/904318/Binding_surface_with_residues/3'>interacting residues of ALK and ALKAL</scene> | ||
+ | <scene name='90/904318/Alk-alkal_binding_surface/2'>ALK-ALKAL binding surface</scene> | ||
+ | <scene name='90/904318/Glycinerichdomain/1'>structure of the glycine-rich domain</scene> | ||
+ | <scene name='90/904318/Alkalbindingsurfacewmembrane/1'>Binding surface of ALKAL with the membrane</scene> | ||
+ | <scene name='90/904318/Alkal1membraneinteraction/2'>ALKAL's residues that interact with membrane</scene> | ||
[[Image:2d_image.jpg|400 px|center|thumb|Fig.1 Anaplastic Lymphoma Kinase and its domains. The region from NTR to the MAM is the Heparin Binding Domain. The TNFL-PXL are the extracellular domains and the EGF is the domain that binds the extracellular region with the extracellular region of the transmembrane. The TMH is the transmembrane domain. The kinase domain is the intracellular portion of the ALK.]] | [[Image:2d_image.jpg|400 px|center|thumb|Fig.1 Anaplastic Lymphoma Kinase and its domains. The region from NTR to the MAM is the Heparin Binding Domain. The TNFL-PXL are the extracellular domains and the EGF is the domain that binds the extracellular region with the extracellular region of the transmembrane. The TMH is the transmembrane domain. The kinase domain is the intracellular portion of the ALK.]] | ||
Revision as of 19:41, 27 March 2022
This Sandbox is Reserved from February 28 through September 1, 2022 for use in the course CH462 Biochemistry II taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1700 through Sandbox Reserved 1729. |
To get started:
More help: Help:Editing |
Anaplastic Lymphoma Kinase
|